Today’s Stock Market in 2-Minutes
January 15, 2026
-
-
iPower Provides Market Update on Digital Asset Treasury Execution
January 15, 2026
-
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN
January 15, 2026
-
Solar Drones Unlocking a Multi-Billion-Dollar Flight Economy as Investors Hone in on New Opportunity
January 15, 2026
-
Top News
- The $1.8T Energy Sprint: Why America is Betting Big on Strategic Mineral Platforms January 15, 2026
- Rimini Street Wins Multiple Industry Awards Recognizing AI Innovation, Client-First Culture, Technical Excellence and Business Impact January 15, 2026
- SEALSQ Welcomes the Official Launch of the “Year of Quantum Security 2026” and Confirms Active U.S. Deployments of Post-Quantum Semiconductor Technology January 15, 2026
- Inception Growth Acquisition Limited Announces Additional Contribution to Trust Account to Extend Business Combination Period January 15, 2026
Sequire Spotlight Presents: Biolargo (BLGO) – 45% Revenue Growth & PFAS Tech Driving Market Impact
Dennis Calvert, CEO of Biolargo, shares how the company achieved 45% revenue growth in 2024, driven by its pet product Pooph, which is now in 40,000 stores, and its breakthrough PFAS remediation technology. Biolargo’s strategy focuses on impactful innovations in environmental health, including industrial odor control and medical technology. The company partners with global multinationals to scale solutions and maintain a diversified portfolio. With minimal debt, strong equity, and a growing team of top-tier engineers, Biolargo is positioning itself as a leader in clean tech and environmental remediation.
May 22, 2025Popular Reads
-
Predictive Oncology (NASDAQ: POAI) Third Quarter 2025 Financial Results and Update on Digital Asset Strategy
November 17, 2025
-
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN
TAIZHOU, China, Jan. 15, 2026 (GLOBE NEWSWIRE) — China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (“China SXT” or the “Company”), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements (“TCMHS”), today […]
January 15, 2026
-
Silo Wellness’ Marley One Line of Functional Mushrooms Now Sold On Amazon
October 12, 2021
-
Silo Wellness Announces $3 Million U.S. Sales and Distribution Partnership for Marley One Line of Functional Mushrooms
August 19, 2021
News
-
Today’s Stock Market in 2-Minutes
January 15, 2026
-
Inception Growth Acquisition Limited Announces Additional Contribution to Trust Account to Extend Business Combination Period
January 15, 2026
-
SEALSQ Welcomes the Official Launch of the “Year of Quantum Security 2026” and Confirms Active U.S. Deployments of Post-Quantum Semiconductor Technology
January 15, 2026
-
iPower Provides Market Update on Digital Asset Treasury Execution
January 15, 2026
-
The $1.8T Energy Sprint: Why America is Betting Big on Strategic Mineral Platforms
January 15, 2026
-
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN
January 15, 2026
-
Rimini Street Wins Multiple Industry Awards Recognizing AI Innovation, Client-First Culture, Technical Excellence and Business Impact
January 15, 2026
-
Solar Drones Unlocking a Multi-Billion-Dollar Flight Economy as Investors Hone in on New Opportunity
January 15, 2026